Advanced Discovery Award
Advanced Discovery Award (ADA) To Improve Outcomes For Kidney Cancer Patients
The KCA Announces A New RFP: Advanced Discovery Award (ADA) To Improve Outcomes For Kidney Cancer Patients.
The Kidney Cancer Association is excited to announce the Board of Directors recently approved $1 million in new research funding for two annual $500,000 grant applications targeting the early detection and innovative treatments of kidney cancer.
The purpose of establishing the Advanced Discovery Award (ADA) is to promote the collaboration between a clinician including a urologic oncologist, medical oncologist or radiation oncologist and a predominately research based collaborator (Ph.D., M. D., D. O.) to propose new research that will make an immediate impact in the field of kidney cancer.
Research may include biomarker development, development of novel therapeutic targets, correlative studies associated with ongoing or completed clinical trials, or assays that promote the early detection of kidney cancer. Any and all proposals will be evaluated through the Letter of Intent (LOI) Process.
We look forward to reviewing the innovative applications of the kidney cancer research community and learning how these grants will continue advancing our mission of bringing an end to the death and suffering from renal cancers and envisioning of a world without kidney cancer.
For more information on how to apply for this grant, please click here.